#ERIC2022 Conference Hashtag

European Research Initiative on CLL: New Frontiers in CLL Research
Thu 6th Oct 2022 - Sat 8th Oct 2022 Open dates in Symplur Signals

The live format of the meeting, organized in plenary sessions, will ensure a comprehensive coverage of the latest advancements in CLL research, from basic to translational and clinical, while also fostering fruitful interactions between the international faculty and the attendees, also thanks to the traditional thematic workshops. Plenty of time will be available for comments, discussion, and gett

What is #ERIC2022?

Healthcare Topics

Related Hashtags

The influencers of #ERIC2022

None.

Tweet Activity of #ERIC2022

Created with Highcharts 9.3.318. Jun19. Jun20. Jun21. Jun22. Jun23. Jun24. Jun0Healthcare Social Graph® – Symplur

Latest Tweets

@blhorton
@sitcancerECS @sitcancer
@MarcoRuella
RT @VJHemOnc: @MarcoRuella of @Penn highlights challenges in developing CAR-T therapy for #CLL. Watch his full interview below: 🎥: https:…
@bloodworkapp
RT @VJHemOnc: Could MRD help predict treatment outcomes for patients with CLL? 💭 [REDACTED USER] of [REDACTED USER] shares his thoughts: 🎥:h…
@CyclingDoctor
RT @VJHemOnc: Could MRD help predict treatment outcomes for patients with CLL? 💭 [REDACTED USER] of [REDACTED USER] shares his thoughts: 🎥:h…
@VJHemOnc
Could MRD help predict treatment outcomes for patients with CLL? 💭 [REDACTED USER] of [REDACTED USER] shares his thoughts: 🎥:https://t.co/TUwNxXnizv #ERIC2022 #HemOnc #LeuSM #CLLsm
@CyclingDoctor
RT @VJHemOnc: @MarcoRuella of @Penn highlights challenges in developing CAR-T therapy for #CLL. Watch his full interview below: 🎥: https:…
@VJHemOnc
@MarcoRuella of @Penn highlights challenges in developing CAR-T therapy for #CLL. Watch his full interview below: 🎥: https://t.co/j6JrgVff7D #ERIC2022 #HemOnc #LeuSM #CLLsm #ImmunoOnc #CARTcell
@CyclingDoctor
RT @VJHemOnc: 🎥 [REDACTED USER] shares some insights into the importance of TP53 in CLL at #ERIC2022: 👉https://t.co/TF00cUu2St👈 #CLLsm #…
@VJHemOnc
🎥 [REDACTED USER] shares some insights into the importance of TP53 in CLL at #ERIC2022: 👉https://t.co/TF00cUu2St👈 #CLLsm #LeuSM #HemOnc
@CyclingDoctor
RT @VJHemOnc: Lydia Scarfò discusses the definition of high-risk disease in CLL at #ERIC2022: 👉https://t.co/0JpBNnkmKe👈 #CLLsm #LeuSM
@VJHemOnc
Lydia Scarfò discusses the definition of high-risk disease in CLL at #ERIC2022: 👉https://t.co/0JpBNnkmKe👈 #CLLsm #LeuSM
#ERIC2022 content from Twitter.

Free Analytics and Transcripts for #ERIC2022

Get Transcript Get Analytics

Your Local Time: (Africa/Abidjan)